Company Filing History:
Years Active: 2002-2006
Title: The Innovations of Stephan Lensky
Introduction
Stephan Lensky is a notable inventor based in Kürten, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have therapeutic applications. With a total of 3 patents to his name, Lensky's work focuses on innovative solutions for treating various health conditions.
Latest Patents
One of his latest patents is titled "Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors." This invention relates to substituted phenylcyclohexanecaboxamides, detailing processes for their preparation and their application in medicaments, especially for treating cardiovascular disorders. Another significant patent is "Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect." This invention also focuses on substituted phenylcyclohexanecarboxamides, emphasizing their adenosine-uptake-inhibiting action and their potential use in treating ischaemic brain disorders.
Career Highlights
Stephan Lensky is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to contribute to groundbreaking research and development in the field of medicine.
Collaborations
Throughout his career, Lensky has collaborated with esteemed colleagues such as Joachim Schuhmacher and Holger Paulsen. These collaborations have further enhanced the impact of his inventions and research.
Conclusion
Stephan Lensky's innovative contributions to medicinal chemistry demonstrate his commitment to advancing healthcare solutions. His patents reflect a deep understanding of complex biological processes and a dedication to improving patient outcomes.